BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2005666)

  • 1. Use of activated charcoal to reduce elevated serum phenobarbital concentration in a neonate.
    Veerman M; Espejo MG; Christopher MA; Knight M
    J Toxicol Clin Toxicol; 1991; 29(1):53-8. PubMed ID: 2005666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceleration of the body clearance of phenobarbital by oral activated charcoal.
    Berg MJ; Berlinger WG; Goldberg MJ; Spector R; Johnson GF
    N Engl J Med; 1982 Sep; 307(11):642-4. PubMed ID: 7050705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal.
    Pond SM; Olson KR; Osterloh JD; Tong TG
    JAMA; 1984 Jun; 251(23):3104-8. PubMed ID: 6726981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal.
    Boldy DA; Vale JA; Prescott LF
    Q J Med; 1986 Nov; 61(235):997-1002. PubMed ID: 3659250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of a higher loading dose of phenobarbital in the term newborn.
    Donn SM; Grasela TH; Goldstein GW
    Pediatrics; 1985 Jun; 75(6):1061-4. PubMed ID: 4000780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased phenobarbital absorption with charcoal administration for chronic renal failure.
    Tanaka C; Yagi H; Sakamoto M; Koyama Y; Ohmura T; Ohtani H; Sawada Y
    Ann Pharmacother; 2004 Jan; 38(1):73-6. PubMed ID: 14742799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1986 May; 9(5):437-41. PubMed ID: 3761133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenobarbital and midazolam suppress neonatal seizures in a noninvasive rat model of birth asphyxia, whereas bumetanide is ineffective.
    Johne M; Römermann K; Hampel P; Gailus B; Theilmann W; Ala-Kurikka T; Kaila K; Löscher W
    Epilepsia; 2021 Apr; 62(4):920-934. PubMed ID: 33258158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of phenobarbital overdose with activated charcoal.
    Goldberg MJ; Berlinger WG
    JAMA; 1982 May; 247(17):2400-1. PubMed ID: 7069899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental aspects of phenobarbital dosage requirements in newborn infants with seizures.
    Nahata MC; Masuoka T; Edwards RC
    J Perinatol; 1988; 8(4):318-20. PubMed ID: 3236100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-dose activated charcoal compared to urinary alkalinization for the enhancement of phenobarbital elimination.
    Frenia ML; Schauben JL; Wears RL; Karlix JL; Tucker CA; Kunisaki TA
    J Toxicol Clin Toxicol; 1996; 34(2):169-75. PubMed ID: 8618250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phenobarbital in newborn infants. Overview].
    Staudt F
    Monatsschr Kinderheilkd; 1984 Apr; 132(4):194-202. PubMed ID: 6374432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenobarbital and diphenylhydantoin levels in neonates with seizures.
    Painter MJ; Pippenger C; MacDonald H; Pitlick W
    J Pediatr; 1978 Feb; 92(2):315-9. PubMed ID: 621616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganaxolone versus Phenobarbital for Neonatal Seizure Management.
    Miller SL; Bennet L; Sutherland AE; Pham Y; McDonald C; Castillo-Melendez M; Allison BJ; Mihelakis J; Nitsos I; Boyd BJ; Hirst JJ; Walker DW; Hunt RW; Jenkin G; Wong F; Malhotra A; Fahey MC; Yawno T
    Ann Neurol; 2022 Dec; 92(6):1066-1079. PubMed ID: 36054160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of theophylline toxicity with oral activated charcoal.
    Sessler CN; Glauser FL; Cooper KR
    Chest; 1985 Mar; 87(3):325-9. PubMed ID: 3971756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenobarbital dosing and pharmacokinetics in a neonate receiving extracorporeal membrane oxygenation.
    Elliott ES; Buck ML
    Ann Pharmacother; 1999 Apr; 33(4):419-22. PubMed ID: 10332532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bumetanide potentiates the anti-seizure and disease-modifying effects of midazolam in a noninvasive rat model of term birth asphyxia.
    Welzel B; Johne M; Löscher W
    Epilepsy Behav; 2023 May; 142():109189. PubMed ID: 37037061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of phenobarbital and the bumetanide derivative bumepamine prevents neonatal seizures and subsequent hippocampal neurodegeneration in a rat model of birth asphyxia.
    Johne M; Käufer C; Römermann K; Gailus B; Gericke B; Löscher W
    Epilepsia; 2021 Jun; 62(6):1460-1471. PubMed ID: 33955541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of diazepam serum half life and reversal of coma by activated charcoal in a patient with severe liver disease.
    Traeger SM; Haug MT
    J Toxicol Clin Toxicol; 1986; 24(4):329-37. PubMed ID: 3746988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid sequential phenobarbital treatment of neonatal seizures.
    Gilman JT; Gal P; Duchowny MS; Weaver RL; Ransom JL
    Pediatrics; 1989 May; 83(5):674-8. PubMed ID: 2717283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.